NRP1 and neoplasm: Liu et al. recently discovered neuropilin-1 (Nrp-1) as another immune checkpoint marker which limits CD8+ T cell-mediated anti-tumour response, lowers persistence and promotes terminal exhaustion in tumour-infiltrated T cells [90].